TCL Archive Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer July 26, 2002
TCL Archive New Drug Combination Improves Survival Of Ewing’s Sarcoma, Pediatric Study Finds February 28, 2003
TCL Archive DCCP Board Okays New Projects In Chemoprevention, Other Programs Totaling $5 Million In First Year December 14, 1979
TCL Archive In Brief: Breast Cancer Stamp Unveiled; Payne Moves To MSK; Survivor To Bike Across U.S. July 31, 1998
TCL Archive Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase December 31, 2010
